Sarepta治療 SRPT 深 滬
等待開盤 08-07 09:30:00 美东时间
16.26
-0.490
-2.93%
華盛通- 最 高16.755
- 今 開16.59
- 成交量 1390.46万股
- 最 低 15.82
- 昨 收 16.75
- 總市值 15.98亿
- 52周最高 144.22
- 市盈率 靜 6.95
- 換手率 14.15%
- 52周最低 10.415
- 委 比 -98.24%
- 總股本 9827.70万
- 歷史最高 181.83
- 量 比 0.78
- 振 幅 5.58%
- 歷史最低 0.433
- 每 手 1
- 風險率 19.66%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多'Sarepta hired a Trump-connected firm to lobby on Duchenne treatment'- STAT News
https://www.statnews.com/2025/08/06/sarepta-lobbying-firm-duchenne-michael-best-strategies-connected-to-trump/
今天 01:12
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
What to Expect from Sarepta Therapeutics's Earnings
Sarepta Therapeutics (NASDAQ:SRPT) is preparing to release its quarterly earnin...
08-06 03:06
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Vor Bio has appointed Dallan Murray as Chief Commercial Officer to lead the global market readiness and launch strategy for telitacicept, a novel treatment for autoimmune diseases. Murray, with over 25 years of experience in biotech and pharma, joins from Sarepta Therapeutics, where he oversaw significant product launches, including the first RNA and gene therapies. He will focus on preparing for telitacicept's global commercialization, currently...
08-04 12:30
美股周涨跌榜 | 上市首周受热捧，Figma周涨近270%；乳腺癌药物实验效果积极，CELC周涨近190%
上市首周受热捧，Figma周涨近270%；乳腺癌药物实验效果积极，CELC周涨近190%；FDA人事变动或缓解监管压力，SRPT周涨超33%>>
08-02 10:39
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
08-02 04:52
Newmont reports sale of Orosur Mining shares
Newmont (NYSE:NEM) on Thursday announced the sale of common shares of Orosur Mining Inc. The miner disposed of 29,213,186 shares in a private transaction, for C$0.19 per share, resulting in aggregate...
08-01 13:12
制药巨头扎堆做“减法”：20家药企7月宣布裁员
2025 年已经过半，裁员、削减成本，成为众多药企不得不面对的现实。据 Fierce Biotech 统计，仅在今年 7 月，就有 20 家药企宣布了裁员计划...
08-01 12:49
Sarepta, Replimmune, Capricor rise as FDA’s biologics head departs
Sarepta Therapeutics (NASDAQ:SRPT), Replimune (NASDAQ:REPL), and Capricor Therapeutics (NASDAQ:CAPR), which faced regulatory setbacks from the FDA’s biologics division, recently witnessed sharp increa...
07-30 22:27
Barclays Upgrades Sarepta Therapeutics to Equal-Weight, Raises Price Target to $22
Barclays analyst Gena Wang upgrades Sarepta Therapeutics (NASDAQ:SRPT) from Underweight to Equal-Weight and raises the price target from $10 to $22.
07-30 21:07
